US Stock MarketDetailed Quotes

BIORQ Biora Therapeutics

Watchlist
  • 0.178
  • 0.0000.00%
15min DelayClose Jan 24 16:00 ET
0Market Cap0.00P/E (TTM)

Biora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biora Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 230.000K--
--2024/Q332.000K / 210.000K--
--2024/Q2318.000K / 0.000--
--2024/Q1542.000K / 0.000--
--2023/Q40.000 / 500.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 230.000K--
--2024/Q332.000K / 210.000K--
--2024/Q2318.000K / 0.000--
--2024/Q1542.000K / 0.000--
--2023/Q40.000 / 500.000--

Unlock Free Earnings Estimates

Biora Therapeutics Earnings Reports

  • Biora Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 16:17 ET

  • Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

    Nov 14, 2024 16:12 ET

  • Biora Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12, 2024 16:38 ET

  • Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

    Aug 12, 2024 16:17 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Collegium Pharmaceutical
    COLL
    +2.36%
    Constellation Brands
    STZ
    +2.01%
    Ermenegildo Zegna NV
    ZGN
    +1.57%
    DexCom
    DXCM
    +1.20%
    Workday
    WDAY
    +1.17%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 2, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data